AN
Abira Nath
About Abira Nath
Data last updated:
Abira Nath is an Additional Director at Bluegreen Pharmaceuticals Private Limited (since 2026). The company operates in Pharma. Bluegreen Pharmaceuticals Private Limited reported revenue of ₹96,592 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bluegreen Pharmaceuticals Private Limited U46497WB2023PTC263335 | Additional Director | 15 Jan 2026 | ₹96,592 (FY 2025) | Active |
Board colleagues of Abira Nath
| Name | DIN | Company | Designation |
|---|---|---|---|
| Debanjan Sarkar | 11483639 | Bluegreen Pharmaceuticals Private Limited | Additional Director |
| Jhuma Sutradhar Sarkar | 10228821 | Bluegreen Pharmaceuticals Private Limited | Director |
| Kalpana Paul Das | 10322025 | Bluegreen Pharmaceuticals Private Limited | Director |
| Suparna Mitra | 11483652 | Bluegreen Pharmaceuticals Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Abira Nath
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Abira Nath
Abira Nath currently holds 1 directorship: Bluegreen Pharmaceuticals Private Limited (Additional Director, since 15 Jan 2026, revenue ₹96,592 (FY 2025)).
Abira Nath was first appointed on 15 Jan 2026 as Additional Director at Bluegreen Pharmaceuticals Private Limited.
The current boards of Abira Nath's companies include Debanjan Sarkar (Bluegreen Pharmaceuticals Private Limited), Jhuma Sutradhar Sarkar (Bluegreen Pharmaceuticals Private Limited), Kalpana Paul Das (Bluegreen Pharmaceuticals Private Limited), Suparna Mitra (Bluegreen Pharmaceuticals Private Limited).